image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Scapa - Healthcare enjoys 20% profit growth

January 2016

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SCPA
  • Price:
  • 206p
The shares continue to bobble near their high while interims showed a strong 18% increase in pretax profit to £9.7m (helped by a 1% rise in trading margin to 8.4%) on sales that rose 4% to £119m. Eps increased a quarter to 5p, while net debt doubled to £6.8m.Healthcare, which supplies advanced woundcare products and medical tapes, increased sales 21% to £43.4m with profit up 20% at £6.5m, helped by ongoing outsourcing trends. First Water, which was acquired last February, performed well and will trigger full pay out of its first year earn-out.Industrial (tapes for industrial and transport applications), grew profit 13% to £5.1m in spite of a 4% fall in sales to £75.9m. Despite challen ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X